Finally, the activation of signal pathways related to Epidermal Growth Factor Receptor (EGFR), Focal Adhesion Kinase (FAK), and NF-κB exerts several activities to provide protection against CDDP-related death signals in OSCC cancer cells and are commonly reported in this subgroup of patients [33]. This evidence concerns the gene NFKB1 and cancer.